Labcorp Holdings Inc. (LH)
$366.57+3.27+0.90%Nov 6
Loading chart…
M.Cap$29.8B
Dividends$2.88 (0.79%, )
Next report—
Forecast
Target
P/E21.2
P/S2.03
P/B3.36
5-y avg sales growth+0.0%
Debt / EBITDA3.58
ROE10.2%
Altman Z-score3.05 (safe)
RSI77
MFI79
Price / MA50+12.6% (v.high) ↑
Trend pattern
Financial Statements
No data available
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
About

Labcorp is a global life sciences company that provides essential information to assist doctors and patients in making clear and informed decisions. Labcorp operates in two divisions: Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD), providing various tests and services. It offers end-to-end drug development, medical device, and companion diagnostic development solutions for entities ranging from early-stage research to commercial market access.

https://www.labcorp.com
Beta 0.85